Moderna Inc. Stock Climbs 5.6%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Moderna Inc. advanced 5.6% to $182.56 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.5% to 27,244.28 and the Dow Jones Industrial Average falling 0.4% to 51,863.69.

This was the stock's second consecutive day of gains.

Moderna Inc. hit a new 52-week high, surpassing its previous peak of $176.86, which the company achieved on September 21st.

The stock outperformed some of its peers, as Johnson & Johnson fell 0.1% to $269.19, Pfizer Inc. rose 0.7% to $27.93, and Gilead Sciences Inc. rose 1.40% to $152.67.

Trading volume totaled 23.7 million, compared to the 50-day average of 18.1 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

September 22, 2026 16:33 ET (20:33 GMT)